<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">healthcare</journal-id><journal-title-group><journal-title xml:lang="ru">Здравоохранение. Healthcare</journal-title><trans-title-group xml:lang="en"><trans-title>Healthcare</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-7218</issn><publisher><publisher-name>Republican Scientific and Practical Center for Medical Technologies, Informatization, Management and Health Economics</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.65249/1027-7218-2026-9-35-44</article-id><article-id custom-type="elpub" pub-id-type="custom">healthcare-372</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ИССЛЕДОВАНИЯ И РАЗРАБОТКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC RESEARCH AND DEVELOPMENT</subject></subj-group></article-categories><title-group><article-title>Результаты эпидемиологического мониторинга в отделении интенсивной терапии хирургического профиля:  проспективное одноцентровое исследование</article-title><trans-title-group xml:lang="en"><trans-title>Results of epidemiological surveillance in a surgical intensive care unit: a prospective single-center study</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-7979-5613</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузьменкова</surname><given-names>Л. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuzmenkova</surname><given-names>L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кузьменкова Лариса Леонидовна – зав. отделением клинической фармакологии и инфекционного контроля</p><p>Ул. Семашко 8, 220045, г. Минск</p><p>Сл. тел. +375 17 243-10-73 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5274-2714</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Прилуцкий</surname><given-names>П. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Prilutsky</surname><given-names>P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Прилуцкий Павел Сергеевич</p><p>г. Минск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1965-1850</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дзядзько</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Dzyadzko</surname><given-names>A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дзядзько Александр Михайлович</p><p>г. Минск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0569-6150</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щерба</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Shcherba</surname><given-names>A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Щерба Алексей Евгеньевич</p><p>г. Минск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7023-4767</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Руммо</surname><given-names>О. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Rummo</surname><given-names>O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Руммо Олег Олегович</p><p>г. Минск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Минский научно-практический центр хирургии, трансплантологии и гематологии</institution><country>Belarus</country></aff><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>20</day><month>10</month><year>2026</year></pub-date><volume>1</volume><issue>9</issue><fpage>35</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кузьменкова Л.Л., Прилуцкий П.С., Дзядзько А.М., Щерба А.Е., Руммо О.О., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Кузьменкова Л.Л., Прилуцкий П.С., Дзядзько А.М., Щерба А.Е., Руммо О.О.</copyright-holder><copyright-holder xml:lang="en">Kuzmenkova L., Prilutsky P., Dzyadzko A., Shcherba A., Rummo O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://healthcare.ejournal.by/jour/article/view/372">https://healthcare.ejournal.by/jour/article/view/372</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Оценить динамику показателей инфекций, связанных с оказанием медицинской помощи (ИСМП), и провести анализ эффективности системы инфекционного контроля в отделении интенсивной терапии (ОИТ) хирургического профиля у пациентов после абдоминальных вмешательств и трансплантации печени и почек.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Проведено одноцентровое проспективное исследование на базе ОИТ хирургического профиля ГУ «Минский научно-практический центр хирургии, трансплантологии и гематологии». За период 2019–2025 гг. пролечено 10 567 пациентов (82,2 % – хирургического профиля, 30,6 % – после трансплантации). Эпидемиологический мониторинг включал регистрацию случаев ИСМП с использованием стандартных определений, микробиологический мониторинг и оценку антибиотикорезистентности. Обработку данных выполняли с использованием программ WHONET 5.6 и IBM SPSS Statistics 26.0.</p></sec><sec><title>Результаты</title><p>Результаты. Общая заболеваемость ИСМП достигла пика в 2021 г. – 12,5 (95 % ДИ (9,7–15,5)) на 100 пациентов, после чего снизилась до 5,6 в 2022 г. и стабилизировалась в 2023–2025 гг. на уровне 4,6–5,9 на 100 пролеченных пациентов. Частота вентилятор-ассоциированных пневмоний (ВАП) снизилась с 27,3 (2021) до 12,8 (2025) на 1000 дней искусственной вентиляции легких (ИВЛ) (p = 0,04). Частота инфекций области хирургического вмешательства снизилась с 1,0 (2019) до 0,5 (2025) на 100 операций (p = 0,03). Отмечено смещение сроков развития поздних инфекций (ВАП – на 10-е сут. ИВЛ, катетер-ассоциированные инфекцие мочевыводящих путей – на 13-е сут. катетеризации). Выявлен рост доли грамположительной флоры (с 25 до 33 %, p = 0,06) и грибов Candida (Candida non-albicans – 58 %, из них C. auris – 31 %). Доля заносов составила 21 % (95 % ДИ (16,7–25,9)). Отмечено увеличение чувствительности основных грамотрицательных возбудителей к карбапенемам и полимиксинам (p &lt; 0,05 для большинства сравнений).</p></sec><sec><title>Заключение</title><p>Заключение. Внедрение эпидемиологического мониторинга, соблюдение мер инфекционного контроля и оптимизация антибактериальной терапии снижает частоту ИСМП и распространенность карбапенем-устойчивых микроорганизмов, а также минимизирует последствия заносов эпидемиологически значимых патогенов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To evaluate the trends in healthcare-associated infection (HAI) rates and analyze the effectiveness of the infection control system in a surgical anesthesiology and intensive care unit (ICU) among patients undergoing abdominal surgeries and liver or kidney transplantation.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A single-center prospective study was conducted at the ICU of the Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology. Over the period from 2019 to 2025, a total of 10,567 patients were treated (82.2 % – surgical profile, 30.6 % – post-transplant recipients). Epidemiological surveillance included registration of HAIs using standard case definitions, microbiological monitoring, and assessment of antimicrobial resistance. Data processing was performed using WHONET 5.6 and IBM SPSS Statistics 26.0 software.</p></sec><sec><title>Results</title><p>Results. The overall incidence of healthcare-associated infections (HAIs) peaked in 2021 at 12.5 (95 % CI (9.7–15.5)) per 100 patients, then decreased to 5.6 in 2022 and stabilized in 2023–2025 at 4.6–5.9 per 100 treated patients. The rate of ventilatorassociated pneumonia decreased from 27.3 (2021) to 12.8 (2025) per 1000 ventilator-days (p = 0.04). The rate of surgical site infections decreased from 1.0 (2019) to 0.5 (2025) per 100 operations (p = 0.03). A shift in the timing of late-onset infections was noted (VAP – on day 10 of mechanical ventilation, CAUTI – on day 13 of catheterization). An increase in the proportion of Gram-positive flora (from 25 to 33 %, p = 0.06) and Candida fungi (Candida non-albicans – 58%, including C. auris – 31 %) was revealed. The proportion of imported cases was 21% (95 % CI (16.7–25.9)). An increase in the susceptibility of major Gram-negative pathogens to carbapenems and polymyxins was observed (p &lt; 0.05 for most comparisons).</p></sec><sec><title>Conclusion</title><p>Conclusion. The implementation of epidemiological surveillance, adherence to infection control measures, and optimization of antimicrobial therapy are associated with a reduction in HAI incidence and the prevalence of carbapenem-resistant microorganisms, as well as with a mitigation of the consequences of imported epidemiologically significant pathogens.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>инфекции</kwd><kwd>связанные с оказанием медицинской помощи</kwd><kwd>отделение интенсивной терапии</kwd><kwd>трансплантация печени</kwd><kwd>трансплантация почки</kwd><kwd>вентилятор-ассоциированная пневмония</kwd><kwd>катетер-ассоциированные инфекции</kwd><kwd>микробиологический мониторинг</kwd><kwd>антибиотикорезистентность</kwd><kwd>инфекционный контроль</kwd></kwd-group><kwd-group xml:lang="en"><kwd>healthcare-associated infections</kwd><kwd>intensive care unit</kwd><kwd>liver transplantation</kwd><kwd>kidney transplantation</kwd><kwd>ventilatorassociated pneumonia</kwd><kwd>catheter-associated infections</kwd><kwd>microbiological monitoring</kwd><kwd>antimicrobial resistance</kwd><kwd>infection control</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Epidemiology of healthcare-associated infection reported from a hospital-wide incidence study: considerations for infection prevention and control planning / S. Stewart, C. Robertson, J. Pan [et al.] // Journal of Hospital Infection. – 2021. – Vol. 114. – P. 10–22.</mixed-citation><mixed-citation xml:lang="en">Stewart S., Robertson C., Pan J., et al. Epidemiology of healthcare-associated infection reported from a hospital-wide incidence study: considerations for infection prevention and control planning. J Hosp Infect. 2021; 114: 10–22.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">The costs of nosocomial infections / M. L. Kilgore, K. Ghosh, C. M. Beavers [et al.] // Medical Care. – 2008. – Vol. 46, № 1. – P. 101–104.</mixed-citation><mixed-citation xml:lang="en">Kilgore M.L., Ghosh K., Beavers C.M., et al. The costs of nosocomial infections. Med Care. 2008; 46(1): 101–104.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Predisposing factors of nosocomial infections in hospitalized patients in the United Kingdom : systematic review / S. S. Isigi, A. D. Parsa, I. Alasqah [et al.] // JMIR Public Health and Surveillance. – 2023. – Vol. 9. – doi: 10.2196/43743.</mixed-citation><mixed-citation xml:lang="en">Isigi S.S., Parsa A.D., Alasqah I., et al. Predisposing factors of nosocomial infections in hospitalized patients in the United Kingdom. JMIR Public Health Surveill. 2023; 9. doi: 10.2196/43743.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Healthcare associated infection and its risk factors among patients admitted to a tertiary hospital in Ethiopia : longitu- dinal study / S. Ali, M. Birhane, S. Bekele [et al.] // Antimicrobial Resistance and Infection Control. – 2018. – Vol. 7. – doi: 10.1186/s13756017-0298-5.</mixed-citation><mixed-citation xml:lang="en">Ali S., Birhane M., Bekele S., et al. Healthcare associated infection and its risk factors among patients admitted to a tertiary hospital in Ethiopia. Antimicrob Resist Infect Control. 2018; 7. doi: 10.1186/s13756-017-0298-5.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuber- culosis / E. Tacconelli, E. Carrara, A. Savoldi [et al.] // The Lancet Infectious Diseases. – 2018. – Vol. 18, № 3. – P. 318–327.</mixed-citation><mixed-citation xml:lang="en">Tacconelli E., Carrara E., Savoldi A., et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018; 18(3): 318–327.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Antibiotic Resistance Threats in the United States, 2019. – Atlanta, GA : U.S. Department of Health and Human Services, CDC, 2019. – URL: https://www.cdc.gov/antimicrobial-resistance/media/pdfs/2019-ar-threats-report-508.pdf (date of access: 07.07.2026).</mixed-citation><mixed-citation xml:lang="en">Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA : U.S. Department of Health and Human Services, CDC; 2019. Available at: https://www.cdc.gov/antimicrobial-resistance/media/pdfs/2019-ar-threats-report-508.pdf (accessed: 06.07.2026).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Surveillance of antimicrobial resistance in Europe, 2021 data / European Centre for Disease Prevention and Control. – Stockholm : ECDC, 2022. – URL: https://iris.who.int/server/api/core/bitstreams/42fd72b9-a207-4659-ad4d-b6f24146ea83/content (date of access: 07.07.2026).</mixed-citation><mixed-citation xml:lang="en">Surveillance of antimicrobial resistance in Europe, 2021 data / European Centre for Disease Prevention and Control. Stockholm: ECDC, 2022. Available at: https://iris.who.int/server/api/core/bitstreams/42fd72b9-a207-4659-ad4d-b6f24146ea83/content (accessed: 06.07.2026).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Орлова О. А. Опыт проведения эпидемиологического наблюдения за вентилятор-ассоциированными инфекциями дыхательных путей / О. А. Орлова, В. Г. Акимкин // Эпидемиология и инфекционные болезни. – 2018. – Т. 23, № 1. – С. 21–26.</mixed-citation><mixed-citation xml:lang="en">Orlova O.A., Akimkin V.G. Experience of conducting epidemiological surveillance of ventilator-associated respiratory tract infections. Epidemiologiya i infekcionnye bolezni. 2018; 23(1): 21–26. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">WHO fungal priority pathogens list to guide research, development and public health action. – 1st ed. – Geneva, Switzer- land : World Health Organization, 2022. – URL: https://iris.who.int/server/api/core/bitstreams/69af4379-4f27-4ac4-897374d7b52af7bd/content (date of access: 06.07.2026).</mixed-citation><mixed-citation xml:lang="en">World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action. Geneva, Switzerland; 2022. Available at: https://iris.who.int/server/api/core/bitstreams/69af4379-4f27-4ac4-8973-74d7b52af7bd/content (accessed: 06.07.2026).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Distribution and antifungal susceptibility pattern of Candida species from mainland China : a systematic analysis / H. Bilal, M. Shafiq, B. Hou [et al.] // Virulence. – 2022. – Vol. 13, № 1. – P. 1573–1589.</mixed-citation><mixed-citation xml:lang="en">Bilal H., Shafiq M., Hou B., et al. Distribution and antifungal susceptibility pattern of Candida species from mainland China. Virulence. 2022; 13(1): 1573–1589.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Population structure based on microsatellite length polymorphism, antifungal susceptibility profile, and enzymatic activity of Candida auris clinical isolates in Russia / E. Oganesyan, V. Klimenteva, I. Vybornova [et al.] // Journal of Fungi (Basel). – 2025. – Vol. 11, № 1. – doi: 10.3390/jof11010035.</mixed-citation><mixed-citation xml:lang="en">Oganesyan E., Klimenteva V., Vybornova I., et al. Population structure based on microsatellite length polymorphism, antifungal susceptibility profile, and enzymatic activity of Candida auris clinical isolates in Russia. J Fungi (Basel). 2025; 11(1). doi: 10.3390/jof11010035.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Дук, Н. В. Инфекции, связанные с оказанием медицинской помощи: от проблем регистрации заболеваемости до современной оценки ситуации (обзор литературы) / Н. В. Дук, Л. Ю. Щучинова, Н. А. Лукьяненко // Медицина. – 2025. – № 4. – С. 57–71.</mixed-citation><mixed-citation xml:lang="en">Duk N.V., Shchuchinova L.Yu., Luk'yanenko N.A. Healthcare-associated infections: from the problems of morbidity registration to the modern assessment of the situation. Medicina. 2025; 4: 57–71. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Surveillance and reporting of hospital-associated infections – a document analysis of Romanian healthcare legislation evolution over 20 years / A. Coman, D. Pop, F. Muresan [et al.] // Healthcare (Basel). – 2025. – Vol. 13, № 3. – doi: 10.3390/healthcare13030229.</mixed-citation><mixed-citation xml:lang="en">Coman A., Pop D., Muresan F., et al. Surveillance and reporting of hospital-associated infections-a document analysis of Romanian healthcare legislation evolution over 20 years. Healthcare (Basel). 2025; 13(3). doi: 10.3390/healthcare13030229.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
